Pareto Securities' 16th Annual Healthcare Conference

Patient insights to shape development of a dCBT for IPF patients

C21 shows promise against COVID-19 where other drugs have failed

Idiopathic Pulmonary Fibrosis: 5 Things to Know

Vicore’s ATTRACT study shows promise for novel drug C21 against COVID-19 in hospitalised patients

Interview with Ella Radvogin, Clinical Psychologist at Alex Therapeutics